Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$17.79 - $30.86 $62,976 - $109,244
-3,540 Reduced 5.02%
66,930 $1.24 Million
Q4 2023

Jan 26, 2024

BUY
$20.78 - $31.77 $1.46 Million - $2.24 Million
70,470 New
70,470 $2.21 Million
Q2 2022

Aug 10, 2022

SELL
$13.01 - $27.22 $1.3 Million - $2.73 Million
-100,238 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$20.94 - $27.5 $91,298 - $119,900
-4,360 Reduced 4.17%
100,238 $2.43 Million
Q4 2021

Feb 03, 2022

SELL
$16.79 - $27.09 $16,403 - $26,466
-977 Reduced 0.93%
104,598 $2.44 Million
Q3 2021

Nov 10, 2021

SELL
$15.78 - $24.77 $82,545 - $129,571
-5,231 Reduced 4.72%
105,575 $1.75 Million
Q2 2021

Aug 06, 2021

BUY
$19.4 - $27.42 $986,567 - $1.39 Million
50,854 Added 84.82%
110,806 $2.7 Million
Q1 2021

May 13, 2021

SELL
$25.02 - $54.99 $12,459 - $27,385
-498 Reduced 0.82%
59,952 $1.55 Million
Q4 2020

Feb 12, 2021

SELL
$41.04 - $56.79 $57,948 - $80,187
-1,412 Reduced 2.28%
60,450 $3.23 Million
Q3 2020

Nov 13, 2020

SELL
$36.42 - $57.0 $358,518 - $561,108
-9,844 Reduced 13.73%
61,862 $2.55 Million
Q2 2020

Aug 06, 2020

SELL
$39.26 - $52.73 $1.23 Million - $1.65 Million
-31,370 Reduced 30.43%
71,706 $3.48 Million
Q1 2020

May 11, 2020

SELL
$31.65 - $46.87 $143,501 - $212,508
-4,534 Reduced 4.21%
103,076 $4.36 Million
Q4 2019

Feb 11, 2020

SELL
$36.21 - $51.4 $27,012 - $38,344
-746 Reduced 0.69%
107,610 $4.6 Million
Q3 2019

Nov 14, 2019

SELL
$22.22 - $44.01 $13,398 - $26,538
-603 Reduced 0.55%
108,356 $3.9 Million
Q2 2019

Aug 12, 2019

BUY
$23.32 - $28.12 $1,655 - $1,996
71 Added 0.07%
108,959 $2.91 Million
Q1 2019

May 13, 2019

BUY
$16.17 - $27.38 $31,903 - $54,020
1,973 Added 1.85%
108,888 $2.92 Million
Q4 2018

Feb 12, 2019

SELL
$14.32 - $22.92 $763,256 - $1.22 Million
-53,300 Reduced 33.27%
106,915 $1.73 Million
Q3 2018

Nov 13, 2018

SELL
$13.03 - $21.81 $61,710 - $103,292
-4,736 Reduced 2.87%
160,215 $3.33 Million
Q2 2018

Aug 09, 2018

BUY
$15.07 - $22.34 $839,203 - $1.24 Million
55,687 Added 50.97%
164,951 $2.52 Million
Q1 2018

May 11, 2018

BUY
$22.47 - $32.33 $1.39 Million - $1.99 Million
61,700 Added 129.72%
109,264 $2.46 Million
Q4 2017

Jan 31, 2018

SELL
$26.84 - $39.14 $2,335 - $3,405
-87 Reduced 0.18%
47,564 $1.43 Million
Q3 2017

Oct 18, 2017

BUY
$29.49 - $38.37 $1.41 Million - $1.83 Million
47,651
47,651 $1.8 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.